Pharma Stocks in Focus: Semaglutide prices set to drop sharply as generics hit the market – DETAILS – Markets
Pharmaceutical stocks are expected to remain in focus as competition in the domestic market picks up pace following the patent expiry of Semaglutide, a widely prescribed drug for diabetes and weight management. The entry of multiple Indian companies into this space is already triggering a sharp correction in prices, making the treatment more affordable for…
